Eligibility of Metastatic Pancreatic Cancer Patients for First-Line Palliative Intent nab-Paclitaxel Plus Gemcitabine Versus FOLFIRINOX. [electronic resource]
Producer: 20171030Description: 507-511 p. digitalISSN:- 1537-453X
- Adult
- Aged
- Aged, 80 and over
- Albumins -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- British Columbia
- Deoxycytidine -- administration & dosage
- Eligibility Determination -- methods
- Female
- Humans
- Male
- Middle Aged
- Paclitaxel -- administration & dosage
- Palliative Care
- Pancreatic Neoplasms -- drug therapy
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.